ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
Risk Signals
24752 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ROCHE DIAGNOSTICS LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-10 (downtoearth.org.in)
Public Health Priority: Delhi High Court Dismisses Roche's Patent Suit on SMA Drug
Delhi High Court: Public health prioritized over patent rights in ruling on life-saving drug affordability.
Read more
2023-10-23 (reut.rs)
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug
Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster rheumatoid arthritis drug Actemra, according to a filing on Monday in Massachusetts federal court.
Read more
2023-10-10 (dundalkdemocrat.ie)
Inside Track: There are times when it doesn’t pay to be charitable
Regular readers of this page would be familiar with the whinges and hard luck stories that often appear here. Coming up is the re-telling of some of the former, along with a few fresh from the HL department. The closure of the Athletic Grounds: It should never have happened, and mightn’t have ...
Read more
2019-08-16 (swissinfo.ch)
Swiss pharma executive gets US sanction for insider trading
The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.
Read more
2019-08-16 (swissinfo.ch)
Swiss pharma executive gets US sanction for insider trading
The US Securities and Exchange Commission has fined Lorenz Erne, a former senior executive at Swiss pharmaceutical firm Roche, for insider trading.
Read more
2016-09-21 (afr.com)
Simonds buyback scheme threatened over payment to ex-CEO Paul McMahon
Former CEO claims founding family's takeover bid was designed to frustrate a share incentive payment he is owed.
Read more
(agefi.fr)
Jerome Garnier
Working in emergency-resuscitation services. Roche (2002): several positions within the medical department, including those of medical director anemia-nephrology-transplantation (2010–11) and medical director oncology hematology (2011-14). Bristol Myers Squibb France: director...
Read more